Pharma
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
DenovAI will create an AI-powered platform to discover potential antibodies from scratch, then suggest which ones can be used as effective drugs.
The Copenhagen-based digital health company will work with Novartis to build digital health tools for chronic conditions where they see unmet needs and the potential for disease progression.
Diathrive Health users will have access to Mark Cuban Cost Plus Drug Company's lower-cost diabetes medication and testing supplies.
The Digital Medicine Society partnered with digital health and pharma players like the FDA, Janssen, GSK, Medable and THREAD to build a toolkit aimed at improving diversity in digital research.
It will be used to invest in specialised healthcare logistics and financing, among other plans.
OncoPower users will have access to Cost Plus Drugs' prescriptions through the partners' Medication Savings Suite.
The funds will help the company grow its platform and scale partnerships with life science companies and healthcare systems.
They seek to identify digital predictive biomarkers of narcolepsy and excessive daytime sleeping.
The grocery chain's healthcare division also announced its first trial, a collaboration with Persephone Biosciences.